Prognostic Significance of Cardiac Troponin I Levels in Hospitalized Patients Presenting With Supraventricular Tachycardia

Although cardiac troponin I (cTnI) elevation in patients presenting to the hospital with supraventricular tachycardia (SVT) is well recognized, the prevalence, predictors, and prognostic significance of cTnI elevation associated with SVT presentation are not known. We screened records of all patients presenting to 2 hospitals over a 4-year period with the diagnosis of SVT confirmed by 12-lead electrocardiogram, and who had at least 1 measured cTnI level and at least 1 year of follow-up after discharge. The primary endpoint was the occurrence of 1 of the following outcomes: death, myocardial infarction, or cardiovascular rehospitalization. Seventy-eight patients met the study criteria (54% female; mean age, 62.2 ± 15.8 yr), and 29 patients (37.2%) had an elevated cTnI level of ≥0.06 ng/mL (range, 0.06-7.78 ng/mL). Univariate predictors of elevated cTnI included left ventricular ejection fraction (LVEF) <50%, renal dysfunction, ST-segment depression or left bundle branch block on the electrocardiogram, and moderate or severe regurgitation of any cardiac valve. Predictors of elevated cTnI after multivariate analysis included peak heart rate during SVT (per 15 bpm) (odds ratio [OR], 1.58; 95% confidence interval [CI], 1.01-2.46; p = 0.04) and LVEF <50% (OR, 6.12; 95% CI, 1.40-26.7; p = 0.02). After multivariable adjustment, the presence of elevated cTnI with SVT was associated with increased risk of the primary endpoint of death, myocardial infarction, or cardiovascular rehospitalization (hazard ratio [HR], 3.67; 95% CI, 1.22-11.1; p = 0.02). Mild elevation of cTnI is common in patients presenting to the hospital with SVT, and is associated with increased risk of future cardiovascular events. Further study is needed to determine the mechanisms of SVT-related cTnI elevation and its association with elevated cardiovascular risk. Abbreviations: CAD = coronary artery disease, CI = confidence interval, COPD = chronic obstructive pulmonary disease, cTnI = cardiac troponin I, HR = hazard ratio, ICD = International Classification of Diseases, LBBB = left bundle branch block, LVEF = left ventricular ejection fraction, OR = odds ratio, SVT = supraventricular tachycardia.

[1]  A. Levey,et al.  A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation , 1999, Annals of Internal Medicine.

[2]  P. Touboul,et al.  Serum cardiac troponin I and ST-segment elevation in patients with acute pericarditis. , 2000, European heart journal.

[3]  R. Acherman,et al.  Troponin I Elevation After Supraventricular Tachycardia in a Child with Hypertrophic Cardiomyopathy , 2001, Pediatric Cardiology.

[4]  H. Hart,et al.  Causes of elevated troponin I with a normal coronary angiogram. , 2002, Internal medicine journal.

[5]  Fred S Apple,et al.  European Society of Cardiology and American College of Cardiology guidelines for redefinition of myocardial infarction: how to use existing assays clinically and for clinical trials. , 2002, American heart journal.

[6]  A. Wu,et al.  Multicenter Evaluation of an Automated Assay for Troponin I , 2022 .

[7]  C. Baillard,et al.  Cardiac troponin I in patients with severe exacerbation of chronic obstructive pulmonary disease , 2003, Intensive Care Medicine.

[8]  M. Pfisterer,et al.  Elevated troponin levels in absence of coronary artery disease after supraventricular tachycardia. , 2003, Swiss medical weekly.

[9]  G. Fonarow,et al.  Cardiac Troponin I Is Associated With Impaired Hemodynamics, Progressive Left Ventricular Dysfunction, and Increased Mortality Rates in Advanced Heart Failure , 2003, Circulation.

[10]  C. Roongsritong,et al.  Common causes of troponin elevations in the absence of acute myocardial infarction: incidence and clinical significance. , 2004, Chest.

[11]  C. Henrikson,et al.  Prognostic usefulness of marginal troponin T elevation. , 2004, The American journal of cardiology.

[12]  W. Elikowski,et al.  [Supraventricular tachycardia as a cause of elevated troponin I in a patient with normal coronary arteries]. , 2005, Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego.

[13]  A. Levin,et al.  Prognostic Value of Troponin T and I Among Asymptomatic Patients With End-Stage Renal Disease: A Meta-Analysis , 2005, Circulation.

[14]  Leonid A. Gavrilov,et al.  Mortality of Centenarians: A Study Based on the Social Security Administration Death Master File , 2005 .

[15]  S. Mayer,et al.  Cardiac Troponin Elevation, Cardiovascular Morbidity, and Outcome After Subarachnoid Hemorrhage , 2005, Circulation.

[16]  D. Redfearn,et al.  Supraventricular tachycardia promotes release of troponin I in patients with normal coronary arteries. , 2005, International journal of cardiology.

[17]  Y. Mehta,et al.  Elevated troponin level is not synonymous with myocardial infarction. , 2006, International journal of cardiology.

[18]  R. Favory,et al.  Bench-to-bedside review: Significance and interpretation of elevated troponin in septic patients , 2006, Critical care.

[19]  Hugo A Katus,et al.  Differential diagnosis of elevated troponins , 2006, Heart.

[20]  E. Amsterdam,et al.  Over the speed limit. , 2007, The American journal of medicine.

[21]  M. F. Stewart,et al.  Best practice in primary care pathology: review 10 , 2007, Journal of Clinical Pathology.

[22]  Zachary D. Tebb.  Prognostic Value of Troponins in Acute Pulmonary Embolism: A Meta-Analysis , 2007 .

[23]  D. Atar,et al.  Frequency and significance of troponin T elevation in acute ischemic stroke. , 2007, The American journal of cardiology.

[24]  C. Lotan,et al.  Acute coronary syndrome vs nonspecific troponin elevation: clinical predictors and survival analysis. , 2007, Archives of internal medicine.

[25]  G. Agnelli,et al.  Prognostic Value of Troponins in Acute Pulmonary Embolism: A Meta-Analysis , 2007, Circulation.

[26]  Muhammad Arida,et al.  Positive Troponin in Diabetic Ketoacidosis without Evident Acute Coronary Syndrome Predicts Adverse Cardiac Events , 2008, Clinical cardiology.

[27]  D. Raveh,et al.  Incidence and significance of a positive troponin test in bacteremic patients without acute coronary syndrome. , 2008, The American journal of medicine.

[28]  T. Omland,et al.  Troponin T elevation and long-term mortality after chronic obstructive pulmonary disease exacerbation , 2008, European Respiratory Journal.

[29]  K. George,et al.  Cardiac troponin T release is stimulated by endurance exercise in healthy humans. , 2008, Journal of the American College of Cardiology.

[30]  C. Phillips,et al.  Usefulness of B-type natriuretic peptide and cardiac troponin levels to predict in-hospital mortality from ADHERE. , 2008, The American journal of cardiology.

[31]  P. Rhee,et al.  Significance of troponin elevation after severe traumatic brain injury. , 2008, The Journal of trauma.

[32]  A. Goette,et al.  Acute atrial tachyarrhythmia induces angiotensin II type 1 receptor-mediated oxidative stress and microvascular flow abnormalities in the ventricles , 2009, European heart journal.

[33]  T. Omland,et al.  Determinants of cardiac troponin T elevation in COPD exacerbation – a cross-sectional study , 2009, BMC pulmonary medicine.

[34]  Y. Agzew.  Elevated Serum Cardiac Troponin in Non‐acute Coronary Syndrome , 2009, Clinical cardiology.

[35]  Mihaela C. Blendea,et al.  Troponin T elevation after implanted defibrillator discharge predicts survival , 2009, Heart.

[36]  F. Marte,et al.  Abnormal troponin I levels after supraventricular tachycardia. , 2009, International journal of cardiology.

[37]  Maurizio Centonze,et al.  Pheochromocytoma mimicking a non-ST elevation acute myocardial infarction. , 2009, Cardiology journal.

[38]  A. Legaz-Arrese,et al.  Cardiac Biomarkers and Exercise Duration and Intensity During a Cycle-Touring Event , 2009, Clinical journal of sport medicine : official journal of the Canadian Academy of Sport Medicine.

[39]  M. Hravnak,et al.  Elevated Cardiac Troponin I and Relationship to Persistence of Electrocardiographic and Echocardiographic Abnormalities After Aneurysmal Subarachnoid Hemorrhage , 2009, Stroke.